These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 36983126)

  • 1. Cardiovascular Side Effects of Anthracyclines and HER2 Inhibitors among Patients with Breast Cancer: A Multidisciplinary Stepwise Approach for Prevention, Early Detection, and Treatment.
    Mauro C; Capone V; Cocchia R; Cademartiri F; Riccardi F; Arcopinto M; Alshahid M; Anwar K; Carafa M; Carbone A; Castaldo R; Chianese S; Crisci G; D'Assante R; De Luca M; Franzese M; Galzerano D; Maffei V; Marra AM; Valente V; Giardino F; Mazza A; Ranieri B; D'Agostino A; Rega S; Romano L; Scagliarini S; Sepe C; Vriz O; Izzo R; Cittadini A; Bossone E; Salzano A
    J Clin Med; 2023 Mar; 12(6):. PubMed ID: 36983126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling Precision Cardio-Oncology: Using Human-Induced Pluripotent Stem Cells for Risk Stratification and Prevention.
    Perry TR; Roberts ML; Sunkara B; Maddula R; McLeish T; Gomez J; Lucas J; Rayan D; Patel S; Liang M; Bosnjak ZJ; Brown SA
    Curr Oncol Rep; 2021 May; 23(7):77. PubMed ID: 33937943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial to evaluate the impact of exercise-based cardiac rehabilitation for the prevention of chemotherapy-induced cardiotoxicity in patients with breast cancer: ONCORE study protocol.
    Díaz-Balboa E; González-Salvado V; Rodríguez-Romero B; Martínez-Monzonís A; Pedreira-Pérez M; Palacios-Ozores P; López-López R; Peña-Gil C; González-Juanatey JR
    BMC Cardiovasc Disord; 2021 Apr; 21(1):165. PubMed ID: 33827450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Insights on the Toxicity on Heart and Vessels of Breast Cancer Therapies.
    Lanza O; Ferrera A; Reale S; Solfanelli G; Petrungaro M; Tini Melato G; Volpe M; Battistoni A
    Med Sci (Basel); 2022 May; 10(2):. PubMed ID: 35736347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer Therapeutics-Related Cardiac Dysfunction among Patients with Active Breast Cancer: A Cardio-Oncology Registry.
    Laufer-Perl M; Mor L; Milwidsky A; Derakhshesh M; Amrami N; Moshkovits Y; Arnold J; Topilsky Y; Arbel Y; Rozenbaum Z
    Isr Med Assoc J; 2020 Sep; 22(9):564-568. PubMed ID: 33236555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefits of antihypertensive medications for anthracycline- and trastuzumab-induced cardiotoxicity in patients with breast cancer: Insights from recent clinical trials.
    Rygiel K
    Indian J Pharmacol; 2016; 48(5):490-497. PubMed ID: 27721532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale and design of the PRevention of cArdiac Dysfunction during Adjuvant breast cancer therapy (PRADA II) trial: a randomized, placebo-controlled, multicenter trial.
    Mecinaj A; Gulati G; Heck SL; Holte E; Fagerland MW; Larsen AI; Blix ES; Geisler J; Wethal T; Omland T
    Cardiooncology; 2021 Sep; 7(1):33. PubMed ID: 34579775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant therapy for HER2 positive breast cancer: are anthracyclines still necessary?
    Castrellon AB; Glück S
    Clin Adv Hematol Oncol; 2008 Sep; 6(9):666-72. PubMed ID: 18827789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardio-Oncology: A Focused Review of Anthracycline-, Human Epidermal Growth Factor Receptor 2 Inhibitor-, and Radiation-Induced Cardiotoxicity and Management.
    Domercant J; Polin N; Jahangir E
    Ochsner J; 2016; 16(3):250-6. PubMed ID: 27660573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale and design of the multidisciplinary team IntervenTion in cArdio-oNcology study (TITAN).
    Pituskin E; Haykowsky M; McNeely M; Mackey J; Chua N; Paterson I
    BMC Cancer; 2016 Sep; 16(1):733. PubMed ID: 27629548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac morbidity & mortality in patients with breast cancer: A review.
    Dhir AA; Sawant SP
    Indian J Med Res; 2021 Aug; 154(2):199-209. PubMed ID: 35295010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardio-oncology, the myth of Sisyphus, and cardiovascular disease in breast cancer survivors.
    Mavrogeni SI; Sfendouraki E; Markousis-Mavrogenis G; Rigopoulos A; Noutsias M; Kolovou G; Angeli C; Tousoulis D
    Heart Fail Rev; 2019 Nov; 24(6):977-987. PubMed ID: 31134427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast Cancer Survivorship and Cardiovascular Disease: Emerging Approaches in Cardio-Oncology.
    Xie Y; Collins WJ; Audeh MW; Shiao SL; Gottlieb RA; Goodman MT; Merz CN; Mehta PK
    Curr Treat Options Cardiovasc Med; 2015 Dec; 17(12):60. PubMed ID: 26490280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in Cardiovascular Biomarkers With Breast Cancer Therapy and Associations With Cardiac Dysfunction.
    Demissei BG; Hubbard RA; Zhang L; Smith AM; Sheline K; McDonald C; Narayan V; Domchek SM; DeMichele A; Shah P; Clark AS; Fox K; Matro J; Bradbury AR; Knollman H; Getz KD; Armenian SH; Januzzi JL; Tang WHW; Liu P; Ky B
    J Am Heart Assoc; 2020 Jan; 9(2):e014708. PubMed ID: 31959034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiotoxicity screening of long-term, breast cancer survivors-The CAROLE (Cardiac-Related Oncologic Late Effects) Study.
    Puckett LL; Saba SG; Henry S; Rosen S; Rooney E; Filosa SL; Gilbo P; Pappas K; Laxer A; Eacobacci K; Kapyur AN; Robeny J; Musial S; Chaudhry A; Chaudhry R; Lesser ML; Riegel A; Ramoutarpersaud S; Rahmani N; Shah A; Papas V; Dawodu T; Charlton J; Knisely JPS; Lee L
    Cancer Med; 2021 Aug; 10(15):5051-5061. PubMed ID: 34245128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac complications in childhood cancer survivors treated with anthracyclines.
    Franco VI; Lipshultz SE
    Cardiol Young; 2015 Aug; 25 Suppl 2():107-16. PubMed ID: 26377717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Overview of Cardio-Oncology, a New Frontier to Be Explored.
    Cheng KH; Wu YW; Hou CJ; Hung CM
    Acta Cardiol Sin; 2021 Sep; 37(5):457-463. PubMed ID: 34584378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer therapeutics-related cardiovascular dysfunction: Basic mechanisms and clinical manifestation.
    Oikawa M; Ishida T; Takeishi Y
    J Cardiol; 2023 Mar; 81(3):253-259. PubMed ID: 35589463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Cardiovascular Disease Risk Factors with Late Cardiotoxicity and Survival in HER2-positive Breast Cancer Survivors.
    He X; Ji J; Dai X; Qdaisat AZ; Esteva FJ; Hortobagyi GN; Yeung SJ
    Clin Cancer Res; 2021 Oct; 27(19):5343-5352. PubMed ID: 34117035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies to Prevent Cardiotoxicity.
    Graffagnino J; Kondapalli L; Arora G; Hawi R; Lenneman CG
    Curr Treat Options Oncol; 2020 Apr; 21(4):32. PubMed ID: 32270293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.